Extra-renal lupus (ERL)

Clinical trials for Extra-renal lupus (ERL) explained in plain language.

Never miss a new study

Get alerted when new Extra-renal lupus (ERL) trials appear

Sign up with your email to follow new studies for Extra-renal lupus (ERL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New antibody aims to tame lupus by targeting troublemaking cells

Disease control Recruiting now

This early-stage study tests a new drug called HB2198 in 30 adults with moderate to severe lupus, including kidney inflammation. The drug is designed to temporarily remove certain immune cells (B cells) that drive the disease. Participants receive two doses and are monitored for …

Matched conditions: EXTRA-RENAL LUPUS (ERL)

Phase 1 • Sponsor: Hinge Bio • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC

Extra-renal lupus (ERL)

Get alerted when new Extra-renal lupus (ERL) trials appear

New antibody aims to tame lupus by targeting troublemaking cells